Meeting
2017 Genitourinary Cancers Symposium
Association of presurgery neutrophil-to-lymphocyte ratio with survival outcomes in patients with urothelial carcinoma treated without neoadjuvant chemotherapy and with radical cystectomy.
Authors
Janet Baack Kukreja
The University of Texas MD Anderson Cancer Center, Houston, TX
Janet Baack Kukreja , Jason M Podolnick , Xuemei Wang , Hsiang-Chun Chen , Neema Navai , Ashish M. Kamat , Colin P.N. Dinney , Jay Bakul Shah
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session B: Prostate Cancer and Urothelial Carcinoma
Track
Prostate Cancer,Urothelial Carcinoma,Prostate Cancer
Sub Track
Urothelial Carcinoma
Citation
J Clin Oncol 35, 2017 (suppl 6S; abstract 324)
DOI
10.1200/JCO.2017.35.6_suppl.324
Abstract #
324
Poster Bd #
F13
Abstract Disclosures
Similar Posters
Poster
2017 Genitourinary Cancers Symposium
Association of preoperative neutrophil-to-lymphocyte ratio with survival outcomes in patients undergoing radical cystectomy, regardless of neoadjuvant chemotherapy status.
First Author: Janet Baack Kukreja
Poster
2016 Genitourinary Cancers Symposium
The utility of neutrophil-to-lymphocyte ratio in determining survival outcomes in patients treated with neoadjuvant chemotherapy and radical cystectomy for high-risk bladder cancer.
First Author: Chinedu O. Mmeje
Poster
2024 ASCO Genitourinary Cancers Symposium
Pathologic and survival outcomes following radical cystectomy for “progressive” and “de novo” muscle-invasive bladder cancer: A meta-analysis stratified by neoadjuvant chemotherapy status.
First Author: Leilei Xia
Poster
2021 ASCO Annual Meeting
Survival outcomes in patients receiving immune checkpoint inhibitor (ICI) for metastatic small cell urothelial cancer (SCUC).
First Author: Omar Alhalabi